Indian drugmakers threaten to strike

Under government pricing pressure,  U.K. drugmakers  threatened to move away and Novartis invoked the old "loss of innovation" argument. Indian drugmakers are putting those protests to shame: Raise the prices on 33 bulk drugs immediately, they're telling the government, or we'll have to stop making them altogether. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.